Company: PACB
Filing Date: 2025-03-17
Form Type: 10-K
Source: 0001299130-25-000061
Chunk: 127

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-03-17
Form: 10-K
Item: Item 1
Chunk 127
---
309,851)(309,851)Other comprehensive income—— — 203 — 203 Issuance of common stock in conjunction with equity plans6,2226 7,697 — — 7,703 Issuance of common stock in conjunction with convertible notes exchange20,45220 36,179 36,199 Share-based compensation expense—— 71,036 — — 71,036 Balance at December 31, 2024294,418$294 $2,654,804 $422 $(2,148,926)$506,594 

See accompanying notes to the consolidated financial statements.

Fiscal 2024 Form 10-K87

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.CONSOLIDATED STATEMENTS OF CASH FLOWSYears Ended December 31,(in thousands)202420232022Cash flows from operating activitiesNet loss$(309,851)$(306,735)$(314,248)Adjustments to reconcile net loss to net cash used in operating activitiesDepreciation 13,774 11,463 9,480 Amortization of intangible assets27,412 8,261 913 Amortization of right-of-use assets12,165 6,810 6,925 Share-based compensation expense71,036 72,118 78,613 Impairment charges184,500 — — Merger-related compensation expense— 3,395 — Loss on extinguishment of debt— 2,033 — Gain on debt restructuring(154,407)— — Accretion of discount and amortization of premium on marketable securities, net(13,044)(12,840)(244)Change in the estimated fair value of contingent consideration(850)15,060 2,377 Inventory provision4,618 10,584 6,027 Deferred income taxes(205)(11,424)— Other(628)1,059 918 Changes in assets and liabilities Accounts receivable, net9,091 (17,829)5,455 Inventory, net(8,320)(13,841)(33,906)Prepaid expenses and other assets 2,228 (8,984)(12,324)Accounts payable 1,405 206 1,025 Accrued expenses (26,342)13,103 (3,